Akers Logo Top  
Akers Logo Bottom
 
 
 
home > investor relations > press releases
Investor Relations - Press Releases

Click on the press release's title to download a PDF.

DATE

TITLE

10 APR 13
Trading Update
27 FEB 13 French Certification for Disposable Breath Alcohol Detectors Received
19 FEB 13 Update on French Certification for Disposable Breath Alcohol Detectors and Product Launch; Trading Update
20 DEC 12 Result of Annual General Meeting
11 DEC 12 3.5m unit Order for Breath Alcohol Tubes; Part Receipt of Licence Fee
10 DEC 12 Notice of Annual General Meeting
26 NOV 12 Distribution Partnership Forged in China
22 OCT 12 Issue of Equity
08 OCT 12 Holding(s) in Company
17 SEP 12 $675,000 Private Placing
17 SEP 12 Interim Results for the Six Months Ended 30 June 2012
28 JUN 12 Preliminary Results for the Year Ended 31 December 2011
30 MAR 12 Holding(s) in Company
20 MAR 12 Appointment of Joint Broker
27 FEB 12 Directorate Change
06 JAN 12 Trading Update
06 DEC 11 Launch of PIFA PLUSS PF4 Rapid Assay
07 SEP 11

Interim Results for the Six Months Ended 30 June 2011

24 AUG 11

ABI Starts Clinical Trials for Breath PulmoHealth “Check” COPD Rapid Assay

30 JUN 11 US$3.2 Million Purchase Order – Revelar Free Radical Assay
10 MAY 11 Result of AGM
28 APR 11 Posting of Annual Report and Accounts and AGM
27 APR 11 Patent for Semi-Quantitative Test Strip
18 APR 11 ABI Starts Clinical Trials for Breath Asthma Check Rapid Assay
11 APR 11 Preliminary Results for the Year Ended 31 December 2010
11 APR 11 Supply Agreement & Acquisition of Breath Condensate Technology
08 APR 11 Conclusion of First HIT Study
16 MAR 11 Patent Protection for Rapid Blood Cell Separator Technology
02 MAR 11 Holdings in Company

10 FEB 11

Issue of Equity - Directors' Holdings

01 FEB 11

Placing to raise £2.0m through the issue of new common shares

14 JAN 11

BreathScan PRO Receives FDA Clearance

05 JAN 11

Trading Statement

29 DEC 10

Product order for Tri-Cholesterol Tests for Middle East

30 SEP 10

Interim Results for the Six Months Ended 30 June 2010

29 SEP 10

PIFA Heparin/Platelet Factor-4 - New Data

06 SEP 10

Product Distribution Expansion: Middle East/India

12 AUG 10

Major PIFA Heparin/PF4 Contract

21 JUL 10

Result of Annual General Meeting

21 JUN 10

Preliminary Results for the Year Ended 31 December 2009

18 JUN 10

Breath Ketone Test - Positive Data

14 JUN 10

USA Distribution Agreement - FISHER HEALTHCARE

09 JUN 10

BreathScan Alcohol Detection - Product Extension

26 MAR 10

Holdings in Company

19 MAR 10

Change of Adviser

17 MAR 10

BreathScan Licensing Agreement - UK and Ireland

16 MAR 10

Clinical Study Data - PIFA Heparin/PF4 Rapid Assay

18 FEB 10

Director/PDMR Shareholding

30 DEC 09

Directorate Changes

17 DEC 09

Holdings in Company

15 DEC 09

ABI Obtains GSA Contract

04 DEC 09

Holdings in Company

26 NOV 09

Holdings in Company

25 NOV 09

Directorate Change

24 NOV 09

Holdings in Company

04 NOV 09

Trading Update

30 SEP 09

Interim Results for the Six Months Ended 30 June 2009

29 SEP 09

ABI Signs Malaria Test Distribution Agreement

13 JUL 09

Result of Annual General Meeting

26 JUN 09

Annual Report and Accounts

25 MAR 09

Director/PDMR Shareholding

24 MAR 09

Preliminary Results for the Year Ended 31 December 2008

19 MAR 09

Holding(s) in Company

11 MAR 09

Notice of Preliminary Results

8 JAN 09

Grant of Warrants

8 JAN 09

Trading Update

5 JAN 09

Technology Transfer and Supply Agreement

Get Adobe Acrobat Reader

   

© 2013 Akers Biosciences, Inc. All Rights Reserved.
Technical Services